{"id":"https://openalex.org/W41365133","doi":null,"title":"Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.","display_name":"Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.","publication_year":2013,"publication_date":"2013-06-01","ids":{"openalex":"https://openalex.org/W41365133","mag":"41365133","pmid":"https://pubmed.ncbi.nlm.nih.gov/23839175"},"language":"en","primary_location":{"id":"pmid:23839175","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23839175","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071907436","display_name":"Lawrence F. Eichenfield","orcid":"https://orcid.org/0000-0002-2760-0474","observed_orcids":["https://orcid.org/0000-0002-2760-0474"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210087384","display_name":"Rady Children's Hospital-San Diego","ror":"https://ror.org/00414dg76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence F Eichenfield","raw_affiliation_strings":["Rady Children's Hospital, San Diego and University of California, San Diego, CA, USA. leichenfield@rchsd.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rady Children's Hospital, San Diego and University of California, San Diego, CA, USA. leichenfield@rchsd.org","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4210087384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040567253","display_name":"Zoe Diana Draelos","orcid":"https://orcid.org/0000-0001-9803-7415","observed_orcids":["https://orcid.org/0000-0001-9803-7415"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zoe Draelos","raw_affiliation_strings":["Duke University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010901410","display_name":"Anne W. Lucky","orcid":"https://orcid.org/0000-0002-6115-7584","observed_orcids":["https://orcid.org/0000-0002-6115-7584"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne W Lucky","raw_affiliation_strings":["CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081828039","display_name":"Adelaide Ann Hebert","orcid":"https://orcid.org/0000-0002-9167-5729","observed_orcids":["https://orcid.org/0000-0002-9167-5729"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adelaide A Hebert","raw_affiliation_strings":["University of Texas Health Science Center at Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center at Houston","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jeffrey Sugarman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Sugarman","raw_affiliation_strings":["University of California at San Francisco,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California at San Francisco,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048521405","display_name":"Linda Stein Gold","orcid":"https://orcid.org/0000-0002-2758-1605","observed_orcids":["https://orcid.org/0000-0002-2758-1605"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Stein Gold","raw_affiliation_strings":["Henry Ford Health System"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System","institution_ids":["https://openalex.org/I154057602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016509243","display_name":"Diane Rudisill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diane Rudisill","raw_affiliation_strings":["Galderma R and D, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma R and D, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hong Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Liu","raw_affiliation_strings":["Galderma R and D, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma R and D, Inc","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073716582","display_name":"Vasant K. Manna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vasant Manna","raw_affiliation_strings":["Galderma R and D, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma R and D, Inc","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.6747,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.94150067,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"12","issue":"6","first_page":"611","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.9750000238418579},{"id":"https://openalex.org/keywords/preadolescents","display_name":"preadolescents","score":0.8119999766349792},{"id":"https://openalex.org/keywords/adapalene","display_name":"adapalene","score":0.8880000114440918},{"id":"https://openalex.org/keywords/benzoyl-peroxide","display_name":"benzoyl peroxide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/topical-gel","display_name":"topical gel","score":0.7829999923706055},{"id":"https://openalex.org/keywords/moderate-acne","display_name":"moderate acne","score":0.5889999866485596},{"id":"https://openalex.org/keywords/lesion-count-reduction","display_name":"lesion count reduction","score":0.7350000143051147},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8830000162124634},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.6919999718666077},{"id":"https://openalex.org/keywords/local-tolerability","display_name":"local tolerance","score":0.7400000095367432},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C2777140388","wikidata":"https://www.wikidata.org/wiki/Q352348","display_name":"Adapalene","level":5,"score":0.9883435368537903},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9460291266441345},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9037430286407471},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.8847947120666504},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7203709483146667},{"id":"https://openalex.org/C2778885487","wikidata":"https://www.wikidata.org/wiki/Q411424","display_name":"Benzoyl peroxide","level":4,"score":0.6540709137916565},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.6269574165344238},{"id":"https://openalex.org/C2776173921","wikidata":"https://www.wikidata.org/wiki/Q25326609","display_name":"Dermatology Life Quality Index","level":3,"score":0.6024739146232605},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5596007704734802},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.539908230304718},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.42996761202812195},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.329861044883728},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.25116223096847534},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.08137667179107666},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C44228677","wikidata":"https://www.wikidata.org/wiki/Q181898","display_name":"Polymerization","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068816","descriptor_name":"Adapalene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001585","descriptor_name":"Benzoyl Peroxide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001585","descriptor_name":"Benzoyl Peroxide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001585","descriptor_name":"Benzoyl Peroxide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005782","descriptor_name":"Gels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23839175","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23839175","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},{"id":"mag:41365133","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23839175","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/12","display_name":"Responsible consumption and production","score":0.4099999964237213}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W44157079","https://openalex.org/W68536699","https://openalex.org/W7215560980","https://openalex.org/W2289204262","https://openalex.org/W4235590505","https://openalex.org/W7162213212","https://openalex.org/W2185568115","https://openalex.org/W2976518386","https://openalex.org/W1785089624","https://openalex.org/W3152714300"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Evaluate":[1],"the":[2,35,88,102],"efficacy":[3],"and":[4,81,98,101,119,125,146,168,183,208,241],"safety":[5],"of":[6,31,63,105,115,139,206],"adapalene":[7],"0.1%-benzoyl":[8],"peroxide":[9],"2.5%":[10],"gel":[11],"(adapalene-BPO)":[12],"in":[13,78,172],"patients":[14],"9-11":[15],"years":[16],"old":[17],"with":[18,28,221,232],"acne":[19,199,214],"vulgaris.":[20],"METHODS:":[21],"Enrolled":[22],"subjects":[23,64,141,193],"were":[24,42,142],"male":[25],"or":[26,47,67],"female,":[27],"a":[29],"score":[30],"3":[32,134],"(moderate)":[33],"on":[34,127,203],"Investigator's":[36],"Global":[37],"Assessment":[38,104],"(IGA)":[39],"scale.":[40],"Subjects":[41],"randomized":[43,143],"to":[44,53,133,144,148,159,236,246],"receive":[45],"adapalene-BPO":[46,145,155,195,234],"vehicle":[48,160],"once":[49],"daily":[50],"for":[51],"up":[52],"12":[54],"weeks.":[55],"Efficacy":[56],"was":[57,111,156,218],"evaluated":[58],"by":[59],"success":[60,163,240],"rate":[61],"(percentage":[62],"rated":[65],"\"clear\"":[66],"\"almost":[68],"clear\")":[69],"at":[70,85,96,107],"each":[71,86],"visit,":[72,87],"median":[73],"percentage":[74,170],"changes":[75],"from":[76,130],"baseline":[77,97],"total,":[79],"inflammatory":[80,179],"non-inflammatory":[82,184],"lesion":[83,174,185,242],"counts":[84,175,186],"Children's":[89],"Dermatology":[90],"Life":[91],"Quality":[92],"Index":[93],"(C":[94],"DLQI)":[95],"week":[99,108],"12,":[100],"Parent":[103],"Acne":[106],"12.":[109],"Safety":[110],"assessed":[112],"through":[113],"evaluations":[114],"adverse":[116],"events":[117],"(AEs)":[118],"local":[120],"tolerability":[121,223],"[erythema,":[122],"scaling,":[123],"dryness,":[124],"stinging/burning":[126],"scales":[128],"ranging":[129],"0":[131],"(none)":[132],"(severe)].":[135],"RESULTS:":[136],"A":[137],"total":[138,173],"142":[140],"143":[147],"vehicle.":[149,247],"At":[150],"study":[151],"endpoint":[152],"(week":[153],"12),":[154],"significantly":[157,215,237],"superior":[158,238],"regarding":[161,169],"treatment":[162,239],"(49.3%":[164],"vs":[165,177,181,188],"15.9%,":[166],"respectively),":[167],"reduction":[171,244],"(68.6%":[176],"19.3%),":[178],"(63.2%":[180],"14.3%),":[182],"(70.7%":[187],"14.6%)":[189],"(all":[190],"P<.001).":[191],"More":[192],"using":[194],"reported":[196],"that":[197,211],"their":[198,204,212],"had":[200],"no":[201],"effect":[202],"quality":[205],"life,":[207],"parents":[209],"noted":[210],"child's":[213],"improved.":[216],"Adapalene-BPO":[217],"well":[219],"tolerated,":[220],"mean":[222],"scores":[224],"less":[225],"than":[226],"1":[227],"(mild).":[228],"CONCLUSIONS:":[229],"In":[230],"preadolescents":[231],"acne,":[233],"leads":[235],"count":[243],"compared":[245]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}